Respiratory failure due to infliximab induced interstitial lung disease

Heart and Lung: Journal of Acute and Critical Care

Volumn 42, Issue 6, 2013, Pages 480-482

  Kakavas, Sotiris ^a   Balis, Evangelos ^a   Lazarou, Vasiliki ^a   Kouvela, Marousa ^a   Tatsis, Georgios ^a  

^a EVANGELISMOS HOSPITAL   (Greece)

Author keywords

Drug induced interstitial pneumonia; Infliximab; Interstitial lung disease; Psoriasis; Tumor necrosis factor inhibitor

Indexed keywords

BRONCHODILATING AGENT; C REACTIVE PROTEIN; FLUCONAZOLE; FUROSEMIDE; INFLIXIMAB; MEROPENEM; MOXIFLOXACIN; PREDNISONE; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTERIAL GAS; ARTICLE; BLOOD PRESSURE; BODY TEMPERATURE; BREATHING RATE; BRONCHOSCOPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; COUGHING; CRACKLE; DRUG INDUCED DISEASE; DRUG TREATMENT FAILURE; DYSPNEA; ECHOCARDIOGRAPHY; EMERGENCY WARD; ERYTHROCYTE SEDIMENTATION RATE; FEVER; HEART ATRIUM ENLARGEMENT; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE; HOSPITAL ADMISSION; HUMAN; HYPOCAPNIA; HYPOXEMIA; INTERSTITIAL LUNG DISEASE; JUGULAR VEIN; LEUKOCYTE COUNT; MALAISE; MALE; MEDICAL HISTORY; OXYGENATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSORIASIS; REPEAT PROCEDURE; RESPIRATORY FAILURE; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 84886946219     PISSN: 01479563     EISSN: 15273288     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2013.07.005     Document Type: Article

References (10)

1. Perez-Alvarez R., Perez-de-Lis M., Diaz-Lagares C., Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases. Semin Arthritis Rheum 2011, 41(2):256-264.
2. Roos J.C., Chilvers E.R., Ostor A.J. Interstitial pneumonitis and anti-tumor necrosis factor-alpha therapy. JRheumatol 2007, 34(1):238-239. [author reply 239].
3. Torii H., Nakagawa H. Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial. JDermatol Sci 2010, 59(1):40-49. Japanese Infliximab Study Investigators.
4. Sen S., Peltz C., Jordan K., Boes T.J. Infliximab-induced nonspecific interstitial pneumonia. Am J Med Sci 2012 Jul, 344(1):75-78.
5. Quang L., Scarpaci A. Infliximab-Induced Interstitial Lung Disease in a Patient With Psoriatic Arthritis. The Jefferson Medicine Forum 2007, 9(26).
6. Leger S., Etienne M., Duval-Modeste A.B., Roussel A., Caron F., Thiberville L. Interstitial pneumonia after infliximab therapy for psoriasis. Ann Dermatol Venereol 2011, 138(6-7):499-503.
7. Bale J., Chee P. Acute alveolitis following infliximab therapy for psoriasis. Australas J Dermatol 2013, 54(1):61-63.
8. El-Hag K., Dercken H.G., Prenzel R., Hölzle E. Drug-induced alveolitis associated with infliximab/azathioprine therapy. Pneumologie 2008, 62(4):204-208.
9. Hagiwara K., Sato T., Takagi-Kobayashi S., Hasegawa S., Shigihara N., Akiyama O. Acute exacerbation of preexisting interstitial lung disease after administration of etanercept for rheumatoid arthritis. JRheumatol 2007, 34(5):1151-1154.
10. Antoniou C., Stefanaki I., Stratigos A., etal Infliximab for the treatment of psoriasis in Greece: 4 years of clinical experience at a single centre. Br J Dermatol 2010, 162(5):1117-1123.